Margit Westphal

Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

Toxicity Testing in the 21st Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways

Evaluation of Drugs With Specific Organ Toxicities in Organ-Specific Cell Lines

The Future of Toxicity Testing